During the past years, there has been a global outbreak of allergic diseases, presenting a
considerable medical and socioeconomical burden. A large fraction of allergic diseases is …

Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

A recent survey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug
Allergy Interest Group (DAIG) on how European allergy specialists deal with beta‐lactam …

Modern health care requires a proactive and individualized response to diseases,
combining precision diagnosis and personalized treatment. Accordingly, the approach to …

Chemotherapeutic drugs have been widely used in the treatment of cancer disease for
about 70 years. The development of new treatments has not hindered their use, and …

Controversies exist with regard to in vivo approaches to delayed immunologically mediated
adverse drug reactions, such as exanthem (maculopapular eruption), drug reaction with …

Drug hypersensitivity may manifest ranging from milder skin reactions (eg, maculopapular
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …

Symptoms) is a complex multisystemic severe drug hypersensitivity reaction whose
diagnosis and management are troublesome. It involves the management by different …

Anaphylaxis is an acute, life-threatening, multisystem syndrome resulting from the sudden
release of mediators by mast cells and basophils. Although anaphylaxis is often under …

Drug-induced hypersensitivity reactions encompass a variety of different clinical phenotypes
ranging from harmless rashes to fatal reactions. They can be classified into allergic (ie drug …